Malaria CVD 36000; Gates INV090205

计划入组 32 人 · 首次发布于 2026 年 4 月 30 日

Frontier Registry II Bifurcation Stent System Registry

首次发布于 2006 年 2 月 3 日

Validation Study of Frontier X Plus (FX+) Device

计划入组 125 人 · 首次发布于 2024 年 6 月 24 日

Teriparatide biosimilar(Frontier Biotechnologies)

KRAS G12C inhibitors (Frontier Medicines)

Influenza therapeutics(Exscientia/Bill & Melinda Gates Foundation)

Frontier Biotechnologies Inc.

China

FRONTIER MEDICINES CORPORATION

United States

Frontier Biotechnologies Inc.

Family Offices Quietly Power Biotech's Funding Comeback, Backing Gene Therapy and AI-Driven Drug Discovery

Dementia Discovery Fund Secures $269M in Second Fund to Accelerate Novel Therapeutics Development

LifeMine Therapeutics Raises $263M to Advance Novel Calcineurin Inhibitor LIFE-001 for Organ Transplant Rejection